interstitial lung disease

Does the pubertal growth affect the occurrence of primary spontaneous pneumothorax?
Tevfik Ilker Akcam, Sukran Darcan, Ali Özdil, Onder Kavurmaci, Ayse Gul Ergonul, Kutsal Turhan, Alpaslan Cakan, Ufuk Cagirici

European Respiratory Journal Sep 2016, 48 (suppl 60) PA580; DOI: 10.1183/13993003.congress-2016.PA580
The Minasarc study: A case-control study measuring mineral exposome in sarcoidosis
Vincent Michel, Cavalin Catherine, Catinon Mikael, Chemarin Cécile, Rio Stephane, Roux Elisabeth, Pecquet Mathieu, Blanchet Anne-Sophie, Vuillermoz Sylvie, Natalizio Audrey, Pison Christophe, Arbib François, Bonneterre Vincent, Valeyre Dominique, Freynet Olivia, Mornex Jean-Francois, Freymond Nathalie, Pacheco Yves, Thivolet Francoise, Kambouchner Marianne, Bernaudin Jean-Francois, Rosental Paul-andré

European Respiratory Journal Sep 2016, 48 (suppl 60) PA397; DOI: 10.1183/13993003.congress-2016.PA397
Videothoracoscopy in the differential diagnosis disseminated pulmonary diseases
Dmitriy Pilkevich, Sergey Skornyakov, Marina Lehlyayder, Aleksey Medyakov, Nikita Gorbunov, Dinar Gatautov

European Respiratory Journal Sep 2016, 48 (suppl 60) PA593; DOI: 10.1183/13993003.congress-2016.PA593
Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF)
Mark Fisher, Toby M. Maher, Steven D. Nathan, Christian Hill, Jade Marshall, Fred Dejonckheere, Per-Olof Thuresson, Nitya Mathew

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4964; DOI: 10.1183/13993003.congress-2016.OA4964
Relationship between nintedanib exposure and adverse events in patients with idiopathic pulmonary fibrosis
Ulrike Schmid, Benjamin Weber, Claudia Dallinger, Luca Richeldi, Christoph Hallmann, Ganesh Raghu, Matthias Freiwald

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4963; DOI: 10.1183/13993003.congress-2016.OA4963
No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib
Toby Maher, Kevin R. Flaherty, Yoshikazu Inoue, Luca Richeldi, Moisés Selman, Wibke Stansen, Susanne Stowasser, Athol Wells

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4959; DOI: 10.1183/13993003.congress-2016.OA4959
Effect of baseline statin use on benefit of nintedanib
Michael Kreuter, Ulrich Costabel, Luca Richeldi, Vincent Cottin, Daniel Wachtlin, Susanne Stowasser, Martin Kolb

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4962; DOI: 10.1183/13993003.congress-2016.OA4962
Long-term treatment with nintedanib in patients with IPF: An update from INPULSIS®-ON
Bruno Crestani, Manuel Quaresma, Mitchell Kaye, Wibke Stansen, Susanne Stowasser, Michael Kreuter

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4960; DOI: 10.1183/13993003.congress-2016.OA4960
SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis
Argyris Tzouvelekis, Guoying Yu, Jose Herazo-Maya, Tony Woolard, Yi Zhang, Hojin Lee, Patty Lee, Erica Herzog, Anton Bennett, Naftali Kaminski

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4979; DOI: 10.1183/13993003.congress-2016.OA4979
LATE-BREAKING ABSTRACT: Role of trans-bronchial lung cryobiopsies in interstitial lung diseases: Preliminary results of a Belgian prospective study
Benjamin Bondue, Thierry Pieters, Patrick Alexander, Paul De Vuyst, Delphine Hoton, Myriam Remmelink, Dimitri Leduc

European Respiratory Journal Sep 2016, 48 (suppl 60) OA4567; DOI: 10.1183/13993003.congress-2016.OA4567

Main menu

User menu

Search

interstitial lung disease

Pages

Contact us